1h Free Analyst Time
The nanoparticle drug delivery systems market is forecasted to grow by USD 54.90 billion during 2023-2028, accelerating at a CAGR of 10% during the forecast period. The report on the nanoparticle drug delivery systems market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the increasing prevalence of chronic diseases, increasing global geriatric population, and increasing government support for research and development in nanotechnology.
The nanoparticle drug delivery systems market is segmented as below:
By Route Of Administration
- Intravenous
- Oral
- Topical
By End-user
- Hospitals and clinics
- Pharmaceutical companies
- Research institutions
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
The report on the nanoparticle drug delivery systems market covers the following areas:
- Nanoparticle Drug Delivery Systems Market sizing
- Nanoparticle Drug Delivery Systems Market forecast
- Nanoparticle Drug Delivery Systems Market industry analysis
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The report presents a detailed picture of the market through study, synthesis, and summation of data from multiple sources by analyzing key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
2 Market Analysis
3 Market Landscape
4 Market Sizing
5 Historic Market Size
6 Qualitative Analysis
7 Five Forces Analysis
8 Market Segmentation by Route of Administration
9 Market Segmentation by End-user
10 Customer Landscape
11 Geographic Landscape
12 Drivers, Challenges, and Opportunity/Restraints
13 Competitive Landscape
14 Competitive Analysis
15 Appendix
List of Exhibits
Executive Summary
The following companies are recognized as the key players in the global nanoparticle drug delivery systems market: Alnylam Pharmaceuticals Inc., Aquestive Therapeutics Inc, CD Bioparticles, CSPC Pharmaceutical Group Ltd., Izon Science Ltd., Jazz Pharmaceuticals Plc, Luye Pharma Group Ltd., Nano Daru Pharmaceutical Co, Nanoform Finland Oyj, NanoMedical Systems, Inc, Nanovex Biotechnologies SL, Precision NanoSystems Inc, Sayre Therapeutics Pvt Ltd, Shanghai Fudan Zhangjiang Bio Pharmaceutical Co Ltd, and Sun Pharmaceutical Industries Ltd..Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is growing innovations in nanomedicine."
According to the report, one of the major drivers for this market is the increasing prevalence of chronic diseases.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Alnylam Pharmaceuticals Inc.
- Aquestive Therapeutics Inc
- CD Bioparticles
- CSPC Pharmaceutical Group Ltd.
- Izon Science Ltd.
- Jazz Pharmaceuticals Plc
- Luye Pharma Group Ltd.
- Nano Daru Pharmaceutical Co
- Nanoform Finland Oyj
- NanoMedical Systems Inc
- Nanovex Biotechnologies SL
- Precision NanoSystems Inc
- Sayre Therapeutics Pvt Ltd
- Shanghai Fudan Zhangjiang Bio Pharmaceutical Co Ltd
- Sun Pharmaceutical Industries Ltd.
